摘要
虽然目前儿童总体新型冠状病毒肺炎(corona virus disease 2019,COVID-19)感染率较低,病情相对轻微,罕见重症病例,病死率显著低于成人,但部分COVID-19可能诱发患儿细胞因子风暴,导致儿童多系统炎症综合征(multisystem inflammatory syndrome in children,MIS-C)。MIS-C病情危重,进展迅速,但若早期明确诊断,及时正确干预,预后则良好。本文归纳了近期有关MIS-C性质、发病机制、流行病学、临床特征及诊治要点的文献,以供临床参考。
Although corona virus disease 2019(COVID-19)is relatively low in children,the condition of illness is relatively mild,and the rare severe cases,the case fatality rate is significantly lower than those in adults.However,some COVID-19 cases may induce cytokines storm in children,leading to multiple system inflammation syndrome in children(MIS-C).MIS-C is critically ill with rapid progress,but if early diagnosis and timely and correct intervention,the prognosis is good.This article summarized the recent literatures on the nature,pathogenesis,epidemiology,clinical features,diagnosis and treatment of MIS-C for clinical reference.
作者
赵惠君
谢晓恬
ZHAO Huijun;XIE Xiaotian(Department of Pediatrics,Suzhou Kowloon Hospital,Shanghai Jiao Tong University School of Medicine,Suzhou 215003,Jiangsu Province,China;Department of Pediatrics,Tongji Hospital ofTongji University,Shanghai 200065,China)
出处
《世界临床药物》
CAS
2021年第1期25-31,共7页
World Clinical Drug
关键词
新型冠状病毒肺炎
儿童多系统炎症综合征
川崎病
流行病学
免疫球蛋白
corona virus disease 2019
multiple system inflammatory syndrome in children
Kawasaki disease
epidemiology
immunoglobulin